![Anna Schwickart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anna Schwickart
No más puestos en curso
Perfil
Anna Schwickart is the founder of Rigontec GmbH, which was founded in 2014.
Antiguos cargos conocidos de Anna Schwickart.
Empresas | Cargo | Fin |
---|---|---|
Rigontec GmbH
![]() Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Rigontec GmbH
![]() Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Anna Schwickart